Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?-Reference-Cited by-同舟云学术

Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?

Published:2016-04-22 Issue:1 Volume:16 Page:
ISSN:1471-2261
Container-title:BMC Cardiovascular Disorders
language:en
Short-container-title:BMC Cardiovasc Disord

Author:

Beton Osman,Saricam Ersin,Kaya Hakki,Yucel Hasan,Dogdu Orhan,Turgut Okan Onur,Berkan Ocal,Tandogan Izzet,Yilmaz Mehmet Birhan

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12872-016-0251-1.pdf

Reference20 articles.

1. Mond HG, Crozier I. The Australian and New Zealand cardiac pacemaker and implantable cardioverter-defibrillator survey: calendar year 2013. Heart Lung Circ. 2015;24:291–7.

2. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, et al. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation. 2014;130:94–125.

3. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127:283–352.

4. Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, et al. Dual antiplatelet therapy and heparin “bridging” significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol. 2010;55:2376–82.

5. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:326–50.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac Resynchronization Therapy Devices Implantation Technique;From Supraventricular Tachycardias to Cardiac Resynchronization Therapy [Working Title];2024-04-12

2. Infections of cardiac implantable electronic devices: Epidemiology, mechanisms, and preventive measures;Kardiologia Polska;2023-10-01

3. Prevention and Management of Cardiac Implantable Electronic Device Infections: State-of-the-Art and Future Directions;Heart, Lung and Circulation;2022-11

4. Current strategies to minimize postoperative hematoma formation in patients undergoing cardiac implantable electronic device implantation: A review;Heart Rhythm;2021-04

5. Reversing Bleeding Associated With Antiplatelet Use: The Role of Tranexamic Acid;Cureus;2020-09-07